Skip to content Skip to sidebar Skip to footer

Newsletter

Biotech Stocks

Telix SEC Subpoena Explained: Why the Stock Plunged 31%

What Investors Need to Know About the Telix SEC Subpoena What happens when a fast-growing biotech lands a major U.S. listing, then suddenly finds itself in the SEC’s crosshairs? That’s the question Telix Pharmaceuticals (ASX:TLX) investors are now asking after the company disclosed it had received a subpoena from the U.S. Securities and Exchange Commission.…

ByCharlie YouldenAugust 8, 2025

Capital Gains Tax on Shares: Here’s How It Works And Whether Or Not the 50% Discount Could Be Wound Back

Capital Gains Tax on Shares is one of the most notable taxes investors will face. Here is Stocks Down Under's Guide with what investors need to know. How CGT works and when do you have to pay it You have to pay a CGT on shares when a 'CGT event' occurs. This involves selling your shares…

ByNick SundichJuly 25, 2025

As ASX Reporting Season for FY25 Looms: Here’s An Investors Ultimate Guide

ASX Reporting Season is almost upon us once again. It is the most important time of the year for investors, a time many reconsider if their thesis still holds, many choose to buy into a stock or sell, some will receive dividends (either expectedly or unexpectedly) whilst others will be disappointed. While you may not…

ByNick SundichJuly 23, 2025

How Trump’s Proposed 200% Tariffs Could Hit CSL (ASX:CSL) and Other Aussie Biotechs

Donald Trump's Tariffs Could Hit CSL and other Aussie Biotechs...it is a reality that is sinking in for many investors. One of the US President's latest proposals — a 200% tariff on imported pharmaceuticals — has sent shockwaves through the healthcare sector. And yes, that includes close allies like Australia. For investors in CSL (ASX: CSL)…

ByUjjwal MaheshwariJuly 17, 2025

Atomo Diagnostics investors are excited about their fair share from Lumos Diagnostics’ A$487m distribution deal

Wednesday 16 July 2025 was a great day for Atomo Diagnostics (ASX:AT1) investors as shares climbed up to 56% higher and closed 25% above the previous day's closing price. The catalyst was an A$487m deal signed by Lumos Diagnostics, one of Atomo's key business partners and investors believe the company will carve out some of…

ByNick SundichJuly 17, 2025

Here are 5 ESG metrics to look at to give you an edge in investing!

Here are 5 ESG metrics to look at! 1. Employee Turnover Common criticisms of ESG metrics is that some have nothing to do with business and are just about expressing advocacy for trendy causes. This criticism is not valid with this one. Because if your investment is bogged down in the cycle of hiring and…

ByNick SundichJuly 15, 2025

Here Are 4 Dogs of the ASX that will Bounce Back With a Vengeance in FY26, and 4 That Won’t

Have you ever heard the term Dogs of the ASX? It can either allude to the worst stocks in the ASX generally, or perhaps the investment strategy of buying these worst performing shares at the start of a new year (either a calendar or financial year), thinking they will rebound. Many will be considering this strategy,…

ByNick SundichJuly 14, 2025

SDI (ASX:SDI): Will slow and steady win the race?

If you're looking for a stock that'll make you a fortune, SDI (ASX:SDI) might not be the best one for you. But if you just want a stock that has little downside risk, it might be more appropriate - but we can only say might. Given the record of dental stocks on the ASX, you might…

ByNick SundichJuly 11, 2025

Botanix Pharmaceuticals (ASX:BOT): Did it deserve to crash over 50% earlier this week?

Botanix Pharmaceuticals (ASX:BOT) crashed over 50% back on Tuesday after an update that left investors disappointed. A crash of this magnitude would suggest the FDA knocked back its drug or that it failed a clinical trial. With Botanix having commercialised its treatment, neither was the case, so it'd have to be a pretty bad sales update.…

ByNick SundichJuly 9, 2025

Here are Our 11 Top ASX Stocks to Buy in FY26: 1 From Each Sector!

It is a New Financial Year, so it's time to outline 11 Top ASX Stocks to Buy in FY26. Why 11 you might ask? Because 11 is the number of 'GICS' (Global Industry Classification Sectors) on the ASX, and we're picking one from each sector. Our 11 Top ASX Stocks to Buy in FY26! Energy: Ampol…

ByNick SundichJuly 7, 2025

the Kick-ass Multipurpose WordPress Theme

Biotech Stocks

Telix SEC Subpoena Explained: Why the Stock Plunged 31%

Capital Gains Tax on Shares: Here’s How It Works And Whether Or Not the 50% Discount Could Be Wound Back

As ASX Reporting Season for FY25 Looms: Here’s An Investors Ultimate Guide

How Trump’s Proposed 200% Tariffs Could Hit CSL (ASX:CSL) and Other Aussie Biotechs

Atomo Diagnostics investors are excited about their fair share from Lumos Diagnostics’ A$487m distribution deal

Here are 5 ESG metrics to look at to give you an edge in investing!

Here Are 4 Dogs of the ASX that will Bounce Back With a Vengeance in FY26, and 4 That Won’t

SDI (ASX:SDI): Will slow and steady win the race?

Botanix Pharmaceuticals (ASX:BOT): Did it deserve to crash over 50% earlier this week?

Here are Our 11 Top ASX Stocks to Buy in FY26: 1 From Each Sector!

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Biotech Stocks

Add Your Heading Text Here